Navigation Links
Researchers find 'secret weapon' used by SARS virus

In 2003, the highly contagious and often-deadly mystery disease now called SARS emerged explosively out of Southern China. It eventually killed an estimated 916 people in Asia, Europe, and North and South America--nearly one in ten of those it infected.

When scientists identified the virus that caused this sudden acute respiratory syndrome, they classified it as a coronavirus--a virus family whose other members cause many common colds. But to there was nothing common about the lethality of SARS; clearly, this coronavirus had some nasty tricks up its sleeve.

Now, in a discovery that suggests a possible new route by which scientists might fashion a vaccine against SARS, researchers at the University of Texas Medical Branch at Galveston (UTMB) have uncovered one of those tricks: a "secret weapon" that the SARS coronavirus uses to sabotage the immune defenses of infected cells. Experiments conducted by the UTMB scientists show that a SARS coronavirus protein called "nsp1" causes the breakdown of biochemical messages that normally prompt the production of a protein critical to defending the body against viruses.

"The SARS nsp1 protein degrades the messenger RNA instructions sent from DNA to make interferon beta, which is crucial to host immunity," said UTMB professor of microbiology and immunology Shinji Makino, senior author of a paper on the discovery to be published online the week of August 7 in the Proceedings of the National Academy of Sciences. "This is a very rare phenomenon, and it raises a lot of questions -- among them, whether we can make a mutant form of SARS coronavirus that lacks the ability to degrade messenger RNA, which could ultimately lead to the creation of a live attenuated vaccine for SARS."

Although many viruses interfere with host cells making messenger RNA or translating it into infection-fighting proteins, only one other virus is known to break down messenger RNA: herpes simplex virus (HSV).

Mak
'"/>

Source:University of Texas Medical Branch at Galveston


Page: 1 2

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain

Post Your Comments:
(Date:11/23/2009)...gton, CT Current research suggests that a common ... The related report by Nichols et al, "Unique Lipi...lass of TLR2 Ligands Capable of Enhancing Autoimmu...American Journal of Pathology . , Multiple scler...ks the brain and spinal cord, affects nearly 1 in ...
(Date:11/23/2009)..., Iowa - The only swine vaccine available for the ... infected with the virus. The vaccination marks th... diagnosed with the pandemic flu., Iowa State Un...e, developed the vaccine this summer and has been ...wa, Kansas and Illinois for several weeks., The ...
(Date:11/23/2009)...N, WI, November 16, 2009 -- A USDOE and USDA study... idle cropland, and cropland pasture could be conv...nial grasses, such as switchgrass, from which biom...ock. Economically viable production of a perennial...es of biomass are removed annually is expected to ...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Labopharm amends debt facility agreement with Hercules 50014 1Labopharm amends debt facility agreement with Hercules 50014 2Labopharm amends debt facility agreement with Hercules 50014 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 1Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 2Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 4OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 1OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 2OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 3
...To help improve the success of oyster restoration ...and Center for Environmental Science researcher Dr...in a new in-depth study to determine when oysters ...ver. Her team,s research is supported by a $750,00...dation. , Working with fellow UMCES Horn Point La...
...f women with breast cancer today are candidates fo... their breast tissue. Results of a UC Davis study,... recurs in the same breast are treated with a seco...rrent treatment recommendations and cutting the nu... were surprised to find that so many women in our ...
..., the oil industry will need more refined tools fo...before taken place, geologists say. , One such to...ment-on-the-move is deposited), derived from sedim... ago, scientists report in this week,s issue of th... entire Paleozoic Era. , "The new Paleozoic sea-l...
Other Biology News:Second lumpectomy for breast cancer reduces survival rates 2Paleozoic 'sediment curve' provides new tool for tracking sea-floor sediment movements 2
(Date:11/25/2009)... BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac B...er of vaccines, announced today that it executed,a... (Dalian) Vaccine,Technology Co., Ltd. (Sinovac Da...commercialize human-use vaccines. Sinovac will con... and commercializing world-class vaccines; the,oth...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...Who: David Appia, French Ambassador for Internatio... in France Agency, , , , ,What: Ambassador Appia ...pro-business initiatives adopted by France to furt...dscape for innovation and development., , ,When: A...
(Date:11/24/2009)...OUIS, Nov. 24 Sigma-Aldr...g at the NASDAQ OMX conference on Tuesday, Decembe...terested parties may listen via live audio broadca... tor.sig m a a ldrich.com/ . Users can clic... About Sigma-Aldrich: Sigma-Aldrich is a leadin...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai B... Administration (SFDA) has approved the,investigat...lin project,(Nodlin), an innovative insulin formul...Biolaxy to initiate its first phase I clinical stu...ic of high blood glucose and poor,metabolism. The ...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
... the Recently Released Strong Results from the, La...ore Human Appendicitis Blood- ba.... 4 AspenBio Pharma,Inc. (Nasdaq: APPY ) an emer...evelopment of novel drugs and diagnostics for anim... Edgewater Research Investor Conference, scheduled...
...dle (Nasdaq: KNDL ), a,leading, global full-servi... that President and Chief Operating Officer Christ...eichroeder Hidden Gems Conference. The,conference ...ew York City,Oct. 8-9, 2007. Kendle,s presentation...ern Time. (Logo: http://www.newscom.com/cgi-bin/...
... Acquisition Corp. (OTC,Bulletin Board: ACAQ), a s...a definitive agreement to acquire Lumen Medical In...opment stage biotechnology company that is,develop... the diagnosis of,Pulmonary Embolism, Pulmonary Hy...e trade name PulmoBind. Under the terms of the agr...
Other Biology Technology:AspenBio Pharma to Present the Edgewater Research Investor Conference 2Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference 2Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 2Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 3Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 4
Anti-Monocarboxylate Transporter 2 (MCT2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Human Relaxin-2, pro- Monoclonal Antibody, Unconjugated, Clone fred from Immundiagnostik
Rabbit Anti-Chicken IgY, IgG F(ab')2 fragment Antibody, Biotin Conjugated from Biomeda Corporation
Anti-Chloride Channel, CLC-2 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: